Le Lézard
Classified in: Health, Science and technology, Business
Subjects: TDS, LIC, FVT

Artisight Announces Systemwide Expansion of AI-Driven Smart Hospital Platform at WellSpan Health


 Pennsylvania health system will expand use of AI-driven virtual sitter and virtual nurse technology to over 1,000 beds on the heels of a successful pilot program.

CHICAGO, Feb. 22, 2024 /PRNewswire/ -- Artisight, Inc., a Smart Hospital Platform powered by industry-defining artificial intelligence to provide virtual care, quality improvement, and care coordination solutions, today announced a systemwide expansion of its collaboration with WellSpan Health. The new program will bring the remote nursing, remote observation, and AI services of Artisight's Smart Hospital Platform to just over 1,000 total beds across the WellSpan Health system.

Artisight's platform was first implemented at WellSpan's Surgery and Rehabilitation Hospital in August 2023. The health system, which counts over 2,000 providers, 220 patient care locations, and eight hospitals, sought a care transformation solution to alleviate nurse burnout and improve outcomes for patients with high fall risk. WellSpan worked with Artisight to train algorithms to respond to these specific needs in the hospital's unique setting. The subsequent pilot program produced clear-cut results ?? including a 15% decrease in patient falls, 21% improvement in patient experience scores related to nurse communication, and an 11% improvement in RN turnover.

"WellSpan's continuing pledge to transform care across its hospitals speaks to its commitment to improve healthcare for clinicians and patients alike," said Stephanie Lahr, MD, CHCIO, president of Artisight. "For too long, we have put burdensome administrative tasks on the backs of our nurses. By automating mundane tasks, Artisight's platform increases efficiencies and elevates care at the bedside. This is how we bring the joy back to medicine."

Artisight's Smart Hospital Platform encompasses AI-driven sensors, computer vision, voice recognition, vital sign monitoring, indoor positioning capabilities, and actionable analytics reports. The platform's deep learning and open integration standards streamline safe patient care and reduce clinician burden. The platform, which is hardware agnostic and can be used with any electronic health record system, integrates into existing technology, ensuring cohesion for hospitals and health systems.

Artisight's approach of solving the first problem first and scaling to address future needs allowed WellSpan to gather quantifiable results and gain internal support for the program's expansion. Full implementation is expected by summer.

"The Artisight Smart Hospital Platform advances our vision for the next generation of care delivery," said Dr. R. Hal Baker, senior vice president and chief digital information officer at WellSpan Health. "When we saw the results of the pilot program ? meaningful safety gains, emphatic support from our nurses, and marked efficiency improvements ? the decision to implement the platform across our health system was easy.  By partnering vigilant technology with the compassionate expertise of our nurses, we can overcome pressing system challenges and positively impact patient outcomes."

"We are laser-focused on the future of care for the patients and community we serve, so being able to add innovative, additional support to our bedside nurses and our patients is outstanding," said Kasey Paulus, senior vice president and chief nursing executive at WellSpan Health. "Even when the caregiver is not in the room, our patient is never alone, supporting a win-win for team members on both sides of the system."

Artisight will exhibit at ViVE 2024 in Los Angeles from Feb 25-28. Visit booth 1918 to learn how the AI-driven Smart Hospital Platform transforms healthcare for hospitals and health systems. Also at ViVE 2024, Dr. Lahr will moderate a panel discussion, "Awakenings: The Perils of AI Success," on Monday, Feb. 26 at 4 p.m. PST at the Hollywood Stage of the Los Angeles Convention Center. For additional information on the company, visit artisight.com.

About WellSpan Health

WellSpan Health's vision is to reimagine healthcare through the delivery of comprehensive, equitable health and wellness solutions throughout our continuum of care. As an integrated delivery system focused on leading in value-based care, we encompass more than 2,000 employed providers, 220 locations, eight award-winning hospitals, home care and a behavioral health organization serving South Central Pennsylvania and northern Maryland. With a team 20,000 strong, WellSpan experts provide a range of services, from wellness and employer services solutions to advanced care for complex medical and behavioral conditions. Our clinically integrated network of 2,600 aligned physicians and advanced practice providers is dedicated to providing the highest quality and safety, inspiring our patients and communities to be their healthiest.

About Artisight

Artisight redefines the possibilities of healthcare through its Smart Hospital Platform and solutions for virtual care, quality improvement, and care coordination. Anchored in deep clinical knowledge and industry-defining artificial intelligence, Artisight's state-of-the-art computer vision and robust multi-sensor network adapts in real-time to specific environments and workflows, unlocking previously inaccessible data and ensuring seamless integration into your healthcare ecosystem.

Media Contact:
Kim Mohr
Amendola Communications for Artisight
[email protected]
949-322-3733

 

SOURCE Artisight


These press releases may also interest you

at 04:00
King Faisal Specialist Hospital and Research Centre (KFSHRC) has successfully performed 5,000 kidney transplants since the inception of its Transplant Program in 1981, placing it among a select group of leading global health centres that have...

at 04:00
IFPA (The International Federation of Psoriasis Associations) concluded its highly anticipated 7th IFPA Conference on World Psoriasis and Psoriatic Arthritis, held from June 27 to 29, 2024, in Stockholm, Sweden. Established in 2006, the conference...

at 03:43
IASO biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, presented the clinical data and single-cell analysis of the fully human...

at 03:37
RaySearch Laboratories AB (publ) announces the launch of RayStation®* 2024B, the latest version of the company's innovative treatment planning system. The new version comes with automation of important clinical workflows, such as automatic image...

at 03:15
TauRx Pharmaceuticals Ltd, a global leader in tau-based research in Alzheimer's disease (AD), has announced the submission of a UK Marketing Authorisation Application (MAA) for hydromethylthionine mesylate (HMTM) for treatment of mild cognitive...

at 03:00
Kedrion Biopharma Inc. announced today that it has established the framework for a long-term agreement with Biotest AG for the full commercialization and distribution of the immunoglobulin therapy Yimmugo® in the U.S., following its...



News published on and distributed by: